Tropic’s non-browning banana secures new key market approvals
UK-based ag-biotech company Tropic secured regulatory approval in both Japan and Brazil for its world-first non‑browning banana variety. The authorizations clear the way for the firm’s fruit to be imported, sold, and consumed in both countries.
Moreover, the firm’s innovation was approved for cultivation in the Latin American country, enabling expanded consumer access, new commercial opportunities, and substantial reductions in global food waste.
“Japan and Brazil each play critical roles in the global fruit market, and these decisions reflect growing international confidence in new agricultural technologies designed for modern supply chains,” said Gilad Gershon, CEO of Tropic.
Two critical markets for Tropic
The latest approvals build on years of scientific development and a growing international regulatory track record across the Americas and Asia, consolidating the company as a global leader in gene‑edited tropical crops.
Japan is a key import market, renowned for exceptionally high standards of quality, freshness, and consistency. Tropic’s non-browning banana complements the stringent market requirements.
In Brazil, one of the world’s largest producers and consumers of bananas, government approval for the ag-biotech’s creation introduces a premium option that reduces waste, improves sustainability, and expands category diversity in the domestic market.
Since its commercial launch in 2025, Tropic’s non-browning banana already has regulatory determinations, notifications, or exemptions for its banana products in eleven countries, including the US, Canada, and the Philippines. These key regions account for more than 70 percent of production and more than 30 percent of consumption.
A banana-filled future
The firm has also commercially launched an extended shelf-life banana variety, which lengthens the green life by an additional 12 days, increasing yields, enabling new export routes, and reducing transportation waste by up to 50 percent.
The UK-based company plans to launch a Panama Disease (TR4) resistant variety in 2027, a $25 billion existential threat for the banana industry.
*All images courtesy of Tropic.
Related stories
Chiquita eyes 2028-30 launch for non-GMO, TR4-resistant bananas
Subscribe to our newsletter
